Trade, Inc.
ENID
Start free

UBC Medical Indonesia Tbk

LABS · Kesehatan · Jasa & Peralatan Kesehatan

138

-2.82% 1-year change

Last completed session, Oct 16, 2026

Daily closes over the past year, to Oct 16, 2026

What makes up the 47

  • Value

    29Against 788 other IDX companies

    Expensive against comparable stocks.

    P/E
    51.1×
    38%Cheaper than 38% of other IDX companies
    P/B
    3.48×
    19%Cheaper than 19% of other IDX companies
    Dividend yield
    —
    —Not ranked

  • Quality

    57Against 788 other IDX companies

    About as profitable as comparable stocks.

    Return on equity
    6.8%
    56%Higher than 56% of other IDX companies
    Return on assets
    4.8%
    63%Higher than 63% of other IDX companies
    Net margin
    5.1%
    52%Higher than 52% of other IDX companies

  • Growth

    57Against 788 other IDX companies

    Growing roughly in line with comparable stocks.

    Profit, last 4 quarters
    +29.7%
    67%Higher than 67% of other IDX companies
    Profit, 3-year yearly
    +68.3%
    91%Higher than 91% of other IDX companies
    Profit, latest quarter vs a year ago
    -26.5%
    35%Higher than 35% of other IDX companies
    Revenue, latest quarter vs a year ago
    +3.7%
    35%Higher than 35% of other IDX companies

  • Momentum

    70Against 836 traded stocks

    Has done better than most stocks over the past year.

    1-year price change
    -2.1%
    70%Better than 70% of traded stocks

  • Liquidity

    32Against 836 traded stocks

    Thinly traded compared with most IDX stocks.

    Value traded per day, 30 days
    IDR 325M
    32%Higher than 32% of traded stocks

  • Retail penalty

    −2Retail brokers XL, XC, RO, YP, past 20 sessions

    Retail is underwater here, deeper than 44% of the other stocks where it is, so 2 points come off the rating.

    Retail average buy
    162
    Close vs that average
    -14.9%
    Retail net bought
    +6.8K lots

Similar stocks

Rated most like LABS across the five pillars. Change is over the past year.